William Blair Initiates Coverage On Faeth Therapeutics with Outperform Rating

William Blair analyst Alethia Young has initiated coverage on Faeth Therapeutics (NASDAQ: FTH) with an Outperform rating. This marks a significant endorsement for the company in the financial markets.